INTRODUCTION

Prof. Dr. Feng Tian is a distinguished academic leader and researcher in the field of medical data science and bioinformatics. Currently, he serves as the Dean of the School of Medicine and the Director of the Hebei Key Laboratory of Medical Data Science at Hebei University of Engineering. His work is focused on integrating artificial intelligence with health big data, contributing significantly to the fields of bioinformatics and public health policy.

EARLY ACADEMIC PURSUITS

Dr. Tian’s academic journey began with a Bachelor’s degree in Biology from Tsinghua University, one of China’s most prestigious institutions. He pursued his Ph.D. in Bioinformatics at Tsinghua University from 2004 to 2009, where his research laid the foundation for his later contributions to the study of molecular biology and bioinformatics. His education provided him with a deep understanding of biological data analysis, which he later applied to medical research.

PROFESSIONAL ENDEAVORS

Dr. Tian’s professional trajectory includes several key academic appointments. He has been a Professor at the School of Medicine, Hebei University of Engineering, since 2021. Prior to this, he gained valuable international experience as a Visiting Scholar at the National Center for Data Mining at the University of Illinois at Chicago (UIC) in 2007-2008. His career has been marked by a commitment to bridging the gap between artificial intelligence and healthcare.

CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Tian’s research interests are multifaceted, focusing on the development and application of AI in health big data, bioinformatics, and public health policy. His research has greatly advanced the understanding of molecular subtyping and the minimal residual disease (MRD) mechanisms in acute lymphoblastic leukemia (ALL). By integrating multi-omics data and utilizing cutting-edge technologies, Dr. Tian has made groundbreaking contributions to the medical field, particularly in the context of cancer research and personalized medicine.

IMPACT AND INFLUENCE

Dr. Tian’s work has had a profound impact on both the scientific community and public health sectors. His AI-driven innovations in medical data analysis are paving the way for more accurate and personalized healthcare. The algorithms and platforms he has developed have not only enhanced tumor diagnosis and drug screening but also contributed to improving public health practices in China. His leadership in the field of medical data science has helped establish Hebei University of Engineering as a leading institution in AI-driven health research.

ACADEMIC CITATIONS AND PUBLICATIONS

Dr. Tian has authored numerous publications in prestigious journals, with his work frequently cited by peers in the bioinformatics and medical research communities. His contributions include groundbreaking studies such as the development of a data processing system for miRNA expression profiling, as well as research into the regulatory impacts of transcription factors across species. More recently, his work has explored deep learning models for prehospital emergency classification and the molecular mechanisms of leukemia. Notable publications include:

1. Tian F, Zhang H, Zhang X, et al. “miRAS: A Data Processing System for miRNA Expression Profiling Study.” BMC Bioinformatics, 2007.

2. Tian F, Wu Y, Zhou Y, et al. “A New Single Nucleotide Polymorphism Genotyping Method.” Clin Chem Lab Med, 2008.

3. Tian F, Xu W, Tian F, et al. “ETV6::ACSL6 Translocation-Driven Super-Enhancer Activation.” Haematologica, 2024.

His academic contributions continue to shape ongoing research in medical data science.

HONORS & AWARDS

Dr. Tian has been the recipient of several prestigious awards, recognizing his contributions to medical research and technology. Notable honors include:

• First Prize, Hebei Provincial Science and Technology Progress Award, for his research on multi-omics AI algorithms in tumor diagnosis and anti-tumor drug screening (September 2024).

• Second Prize, 2024 Invention and Entrepreneurship Achievement Award, China Association of Inventions, for his work in AI models in public health (July 2024).

• First Prize, Hebei Medical Science and Technology Award, for his research on reducing residual risk after nucleic acid testing (May 2021).

These accolades reflect his leadership and innovation in the fields of health big data, bioinformatics, and AI applications in healthcare.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Tian’s legacy in the academic and medical fields is poised for significant growth. His ongoing research aims to further revolutionize the application of artificial intelligence in health data analysis, with an emphasis on cancer research and public health policy. His innovative work continues to shape the future of personalized medicine and healthcare, and he is dedicated to advancing his research in the coming years to further improve public health outcomes globally.

FINAL NOTE

Prof. Dr. Feng Tian stands at the forefront of the intersection between artificial intelligence and healthcare. His pioneering research, leadership, and commitment to applying AI in medical data science have established him as a key figure in his field. With numerous accolades, publications, and ongoing contributions to healthcare and bioinformatics, Dr. Tian’s work continues to inspire the next generation of researchers and healthcare professionals. His legacy will undoubtedly shape the future of medical data science for years to come.

TOP NOTES PUBLICATIONS 

Flynet: a genomic resource for Drosophila melanogaster transcriptional regulatory networks

• • Authors: Not listed in your excerpt, but attributed to the Flynet project

  • Journal: Bioinformatics

  • Year: 2009

---

DL-PER: Deep Learning Model for Chinese Prehospital Emergency Record Classification

• • Authors: X. Zhang, H. Zhang, L. Sheng, F. Tian*

  • Journal: IEEE Access

  • Year: 2022

---

ETV6::ACSL6 translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpression

• • Authors: Xu W*, Tian F*, Tai X, Song G, Liu Y, Fan L, Weng X, Yang E, Wang M, Bornhäuser M, Zhang C, Lock RB, Wong JWH, Wang J, Jing D, Mi JQ

  • Journal: Haematologica

  • Year: 2024

---

 PU.1 eviction at lymphocyte-specific chromatin domains mediates glucocorticoid response in acute lymphoblastic leukemia

• • Authors: Dominik Beck#,, Honghui Cao#, Feng Tian#, Yizhou Huang#, Miao Jiang, Han Zhao, Xiaolu Tai, Wenqian Xu, Hansen J Kosasih, David J Kealy, Weiye Zhao, Samuel J Taylor, Gaoxian Song, Diego Chacon-Fajardo, Yashna Walia, Meng Wang, Adam A Dowle, Andrew N Holding, Katherine S Bridge, Chao Zhang, Jin Wang, Jian-Qing Mi, Richard B Lock, Charles E. de Bock*, Duohui Jing*

  • Journal: Nature Communications

  • Year: 2024

---

 Single-Cell Atlas Reveals Tumorigenic Profiles and Immune Dynamics of Adrenal Incidentalomas

• • Authors: Meng Wang#, Guangmin Zheng#, Xiaoyong Hu#, Feng Tian#, Tuo Li, Zheng Zhang, Kai Gong, Shiwei Chen, Lin Yuan, Yu Qi, Lin Li, Daofu Cheng, Liu Liu, Fuqiang Liu, Yujing Sun, Xiangdong Fang, Ruxing Zhao*, Bing Liu*, Chao Zhang*

  • Journal: Advanced Science

  • Year: 2025

---

Spatial analysis of prehospital emergency medical services accessibility: a comparative evaluation of the GAUSS-probability two-step floating catchment area model in Handan City

• • Authors: Tian F, Lu S, Yang Z, Zhao T, Li P, Zhang H

  • Journal: Frontiers in Public Health

  • Year: 2025